NEW YORK, Feb. 18, 2012 /PRNewswire/ -- Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of SeraCare Life Sciences, Inc. (NASDAQ: SRLS) (referred to as "SeraCare" or the "Company") to Linden Capital Partners ("Linden"), in a cash transaction.

(Logo:  http://photos.prnewswire.com/prnh/20120119/MM38805LOGO )

Under the terms of the agreement, holders of outstanding shares of common stock of SeraCare will receive $4.00 per share.  A special meeting of SeraCare's shareholders will be held after the preparation and filing of a proxy statement with the Securities and Exchange Commission and subsequent mailing to shareholders.  If the merger is approved by shareholders, the transaction is expected to close in the second quarter of calendar year 2012. Upon completion of the acquisition, SeraCare will become a private company, wholly owned by an affiliate of Linden.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.

If you are a holder of SeraCare common stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.  

If you are a shareholder of SeraCare and would like more information about our investigation, please contact Peter D. Bull, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: counsel@nyclasslaw.com.  All e-mail correspondence should make reference to SeraCare.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions.  For more information about the firm, please visit our website at www.nyclasslaw.com.

ATTORNEY ADVERTISING. © 2012 Bull & Lifshitz, LLP.  The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212) 213-6222.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Peter D. Bull, Esq.

Bull & Lifshitz, LLP

Phone:   212-213-6222

Fax:      212-213-9405

Email: counsel@nyclasslaw.com

SOURCE Bull & Lifshitz, LLP

Copyright 2012 PR Newswire

Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas Seracare Life Sciences.
Seracare Life Sciences (NASDAQ:SRLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas Seracare Life Sciences.